Medtronic Revenue Recognized from Contract Liability increased by 513.6% to $135.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $108.00M to $135.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate successful delivery of services or products for which cash was previously received.
Revenue recognized during the current period that was previously recorded as a contract liability (deferred revenue) at...
Commonly disclosed in revenue recognition notes for companies with subscription or long-term contract models.
tmusz_contract_liability_revenue_recognized| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.00M | $76.00M | $32.00M | $87.00M | $129.00M | $124.00M | $72.00M | $78.00M | $108.00M | $121.00M | $22.00M | $135.00M |
| QoQ Change | — | -9.5% | -57.9% | +171.9% | +48.3% | -3.9% | -41.9% | +8.3% | +38.5% | +12.0% | -81.8% | +513.6% |
| YoY Change | — | — | — | +3.6% | +69.7% | +42.5% | -44.2% | — | -12.9% | +68.1% | -71.8% | +25.0% |